Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02819518 |
|---|---|
| Brief Title: | Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355) |
| First Submitted : | June 28, 2016 |
| First Submitted that Met QC Criteria : | June 28, 2016 |
| First Posted : | June 30, 2016 (Estimate) |
| Results First Submitted : | June 8, 2022 |
| Results First Submitted that Met QC Criteria : | June 8, 2022 |
| Results First Posted : | July 5, 2022 |
| Last Update Submitted that Met QC Criteria : | November 6, 2023 |
| Last Update Posted : | November 9, 2023 |